America’s First Therapeutic Cancer Vaccine
Last Thursday the Food and Drug Administration approved Provenge for the treatment of advanced prostate cancer. Provenge is the first therapeutic vaccine to be approved in the U.S. for cancer treatment, ushering in what may be a new era in immune-based cancer treatments. Approval marks the successful conclusion of a 20-year odyssey with some remarkable twists and turns. My part of the story …
Read more on The Atlantic
